We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OGD BUDGET REMAINS FLAT; FIRMS WORRY ABOUT WORKLOAD
OGD BUDGET REMAINS FLAT; FIRMS WORRY ABOUT WORKLOAD
February 6, 2004
Some members of the generic drug industry are vowing to lobby for more funding for FDA’s Office of Generic Drugs (OGD) if it becomes clear the agency isn’t able to handle an increasing workload with a Bush-administration proposed fiscal 2005 budget that keeps funding levels flat.